13F reference period
Q2 2026
Security Snapshot
Medline Inc. - Class A Common Stock, par value $0.0001 per share (MDLN) Institutional Ownership
CUSIP: 58507V107
13F Institutional Holders and Ownership History from Q4 2025 to Q3 2026
Institutions Reporting
409
Shares (Excl. Options)
853.03M
Full value: 853,034,705 · shares · 30 Jun 2026Price
$39.44
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Common Stock, par value $0.0001 per share
- Symbol
- MDLN on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 853,034,705
- Total 13F value
- $33,667,531,613
- Portfolio coverage rank
- 0.02%
- Share change
- +87,608,407
- Value change
- +$3,385,234,315
- Number of holders
- 409
- Shares outstanding
- 879,082,473
- SEC-reported price per share
- $35.70
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- MDLN - Medline Inc. - Class A Common Stock, par value $0.0001 per share is tracked under CUSIP 58507V107.
- 409 institutions reported positions in Q2 2026.
- 7 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 314 to 409 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$28.31B
Full value: $28,310,948,544 · USD · 31 Mar 2026.$33.67B
Full value: $33,667,531,613 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 409 institutions filings for Q2 2026.
Security key
58507V107
13F reference period
Q2 2026
13F holders
409
13D/G owners
7
CIK / CUSIP context first
Open Q2 2026 holders
MDLN full holder history
Medline Inc. SEC filings
Medline Inc. company facts
Medline Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 58507V107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
7
Security
MDLN
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Mozart Holdco, Inc. | 22% | $10,009,650,747 | 234,308,304 | Mozart Holdco, Inc. | 31 Dec 2025 | |||
| Carlyle Group Inc. | 21% | -16% | $8,834,092,928 | -$1,332,516,432 | 187,083,713 | -13% | Carlyle Group Inc. | 31 Mar 2026 |
| Blackstone Holdings II L.P. | 16% | -20% | $6,222,037,052 | -$1,369,820,022 | 153,327,675 | -18% | BMA VIII L.L.C. | 30 Jun 2026 |
| Hellman & Friedman Capital Partners X (Parallel), L.P. | 16% | -19% | $6,222,037,052 | -$1,369,820,022 | 153,327,675 | -18% | Hellman & Friedman Investors X, L.P. | 30 Jun 2026 |
| GIC Private Ltd | 8.5% | -35% | $2,664,437,441 | -$1,418,140,624 | 74,634,102 | -35% | GIC Private Limited | 04 Nov 2026 |
| FMR LLC | 5.5% | $1,904,387,086 | 46,929,204 | FMR LLC | 30 Jun 2026 | |||
| Abu Dhabi Investment Authority | 4.9% | -17% | $1,952,799,155 | -$290,872,225 | 41,355,340 | -13% | Abu Dhabi Investment Authority | 31 Mar 2026 |
As of 30 Jun 2026,
409
institutional investors reported holding
shares of
Medline Inc. - Class A Common Stock, par value $0.0001 per share (MDLN).
This represents
97%
of the company’s total
outstanding shares.
853.03M
Full value: 853,034,705 · shares · 30 Jun 2026879.08M
Full value: 879,082,473 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
83%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Carlyle Group Inc. | 21% | 187,083,713 | 0% | 74% | $7,378,581,641 |
| Blackstone Inc. | 12% | 101,791,008 | -18% | 11% | $4,014,637,356 |
| H&F Corporate Investors X, Ltd. | 8.1% | 70,874,326 | -18% | 100% | $2,795,283,417 |
| FMR LLC | 5.3% | 46,963,203 | +28% | 0.08% | $1,852,228,753 |
| Capital Research Global Investors | 4.5% | 39,963,790 | +73% | 0.22% | $1,576,182,798 |
| Invesco Ltd. | 4.4% | 38,346,937 | +83% | 0.12% | $1,512,403,210 |
| BlackRock, Inc. | 3% | 26,393,587 | +56% | 0.02% | $1,040,963,063 |
| MORGAN STANLEY | 2.5% | 21,605,662 | +38% | 0.05% | $852,127,453 |
| LONE PINE CAPITAL LLC | 2.4% | 20,968,367 | +78% | 5.1% | $826,992,394 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2.3% | 19,888,806 | +72% | 0.27% | $787,117,099 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2% | 17,816,057 | +21% | 0.02% | $702,665,288 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.9% | 16,781,031 | +19% | 0.03% | $661,843,863 |
| Egerton Capital (UK) LLP | 1.9% | 16,470,884 | +277% | 6.3% | $649,611,665 |
| Jupiter Topco LLC | 1.8% | 15,858,400 | 0% | 0.25% | $625,440,654 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 1.4% | 11,956,905 | +173% | 0.37% | $471,580,333 |
| BAILLIE GIFFORD & CO | 1.3% | 11,343,036 | +14% | 0.41% | $447,369,341 |
| NORGES BANK | 0.96% | 8,475,413 | 0.03% | $334,270,289 | |
| STATE STREET CORP | 0.96% | 8,447,035 | +75% | 0.01% | $333,151,060 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.9% | 7,948,506 | +27% | 0.02% | $312,741,786 |
| SurgoCap Partners LP | 0.85% | 7,487,507 | +23% | 9.5% | $295,307,276 |
| WCM INVESTMENT MANAGEMENT, LLC | 0.84% | 7,397,650 | +2.5% | 0.53% | $293,020,917 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 0.84% | 7,355,574 | +47% | 0.41% | $290,103,839 |
| BANQUE PICTET & CIE SA | 0.83% | 7,312,150 | +415% | 3% | $288,391,196 |
| Alyeska Investment Group, L.P. | 0.77% | 6,809,122 | +132% | 0.69% | $268,551,772 |
| UBS Group AG | 0.73% | 6,431,013 | +101% | 0.04% | $253,639,153 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
4
Headline period
Q2 2026
Rows shown
1-4 of 4
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 230,681,243 | $8,004,767,639 | +$2,706,212 | $34.70 | 136 |
| 2026 Q2 | 853,034,705 | $33,667,531,613 | +$3,385,234,315 | $39.44 | 409 |
| 2026 Q1 | 636,659,221 | $28,310,948,544 | +$2,448,451,403 | $44.50 | 314 |
| 2025 Q4 | 569,977,783 | $23,938,711,782 | +$23,896,326,798 | $42.00 | 203 |